KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Biolife Solutions (BLFS) Liabilities from Discontinued Operations (2023)

Historic Liabilities from Discontinued Operations for Biolife Solutions (BLFS) over the last 1 years, with Q4 2023 value amounting to $18.8 million.

Biolife Solutions' Liabilities from Discontinued Operations changed N/A to $18.8 million in Q4 2023 from the same period last year, while for Dec 2023 it was $18.8 million, marking a year-over-year change of. This contributed to the annual value of $18.8 million for FY2023, which is N/A changed from last year.
Biolife Solutions' Liabilities from Discontinued Operations amounted to $18.8 million in Q4 2023.
Biolife Solutions' 5-year Liabilities from Discontinued Operations high stood at $18.8 million for Q4 2023, and its period low was $18.8 million during Q4 2023.